Embecta Past Earnings Performance

Past criteria checks 0/6

Embecta's earnings have been declining at an average annual rate of -44.3%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 0.6% per year.

Key information

-44.3%

Earnings growth rate

-66.3%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate0.6%
Return on equityn/a
Net Margin4.9%
Next Earnings Update09 May 2024

Recent past performance updates

Recent updates

Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15

Feb 21
Embecta's (NASDAQ:EMBC) Dividend Will Be $0.15

Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares

Jul 16
Embecta Corp.'s (NASDAQ:EMBC) Prospects Need A Boost To Lift Shares

Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate

Mar 30
Embecta Corp. (NASDAQ:EMBC) Shares Could Be 37% Below Their Intrinsic Value Estimate

Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 17
Embecta Corp. Just Recorded A 22% EPS Beat: Here's What Analysts Are Forecasting Next

Embecta: Comments On 2nd Earnings Since Spin Off

Sep 04

Some Investors May Be Willing To Look Past Embecta's (NASDAQ:EMBC) Soft Earnings

Aug 23
Some Investors May Be Willing To Look Past Embecta's (NASDAQ:EMBC) Soft Earnings

Embecta GAAP EPS of $1.07 beats by $0.20, revenue of $291.1M beats by $14.24M

Aug 15

Embecta Is A Winner In A Growing Market

Jun 07

Embecta: Not Love At First Sight

Apr 04

Revenue & Expenses Breakdown
Beta

How Embecta makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:EMBC Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,1225535989
30 Sep 231,1217034185
30 Jun 231,1144732880
31 Mar 231,1199432471
31 Dec 221,11616030567
30 Sep 221,13022429567
30 Jun 221,15633828469
31 Mar 221,16038026070
31 Dec 211,16940824966
30 Sep 211,16541524063
30 Sep 201,08642821561
30 Sep 191,10943222262

Quality Earnings: EMBC has a large one-off loss of $19.0M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: EMBC's current net profit margins (4.9%) are lower than last year (14.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EMBC's earnings have declined by 44.3% per year over the past 5 years.

Accelerating Growth: EMBC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EMBC had negative earnings growth (-65.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (6.3%).


Return on Equity

High ROE: EMBC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.